267 related articles for article (PubMed ID: 12865945)
1. Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.
Mabley JG; Rabinovitch A; Suarez-Pinzon W; Haskó G; Pacher P; Power R; Southan G; Salzman A; Szabó C
Mol Med; 2003; 9(3-4):96-104. PubMed ID: 12865945
[TBL] [Abstract][Full Text] [Related]
2. The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.
Mabley JG; Pacher P; Murthy KG; Williams W; Southan GJ; Salzman AL; Szabo C
J Endocrinol; 2008 Sep; 198(3):581-9. PubMed ID: 18562629
[TBL] [Abstract][Full Text] [Related]
3. Inosine improves islet xenograft survival in immunocompetent diabetic mice.
Schneider S; Klein HH
Eur J Med Res; 2005 Jul; 10(7):283-6. PubMed ID: 16055398
[TBL] [Abstract][Full Text] [Related]
4. Nicotine reduces the incidence of type I diabetes in mice.
Mabley JG; Pacher P; Southan GJ; Salzman AL; Szabó C
J Pharmacol Exp Ther; 2002 Mar; 300(3):876-81. PubMed ID: 11861793
[TBL] [Abstract][Full Text] [Related]
5. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
6. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
7. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
8. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
Solomon M; Flodström-Tullberg M; Sarvetnick N
Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
[TBL] [Abstract][Full Text] [Related]
9. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver.
Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M
Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877
[TBL] [Abstract][Full Text] [Related]
10. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
Transplantation; 1998 May; 65(10):1310-4. PubMed ID: 9625011
[TBL] [Abstract][Full Text] [Related]
12. Effects of streptozotocin on autoimmune diabetes in NOD mice.
Koulmanda M; Qipo A; Auchincloss H; Smith RN
Clin Exp Immunol; 2003 Nov; 134(2):210-6. PubMed ID: 14616779
[TBL] [Abstract][Full Text] [Related]
13. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
14. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
15. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
16. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
Mabley JG; Southan GJ; Salzman AL; Szabó C
Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice.
Rydgren T; Vaarala O; Sandler S
J Pharmacol Exp Ther; 2007 Oct; 323(1):180-5. PubMed ID: 17636011
[TBL] [Abstract][Full Text] [Related]
18. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
[TBL] [Abstract][Full Text] [Related]
19. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
